Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Vincenzo Malagnino"'
Autor:
Alessandra Imeneo, Lorenzo Vittorio Rindi, Andrea Di Lorenzo, Rosario Alessandro Cavasio, Pietro Vitale, Ilaria Spalliera, Mario Dauri, Daniele Guerino Biasucci, Ilaria Giuliano, Cartesio D’Agostini, Silvia Minelli, Maria Cristina Bossa, Anna Altieri, Massimo Andreoni, Vincenzo Malagnino, Marco Iannetta, Loredana Sarmati
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Actinomyces turicensis is rarely responsible of clinically relevant infections in human. Infection is often misdiagnosed as malignancy, tuberculosis, or nocardiosis, therefore delaying the correct identification and treatment. Her
Externí odkaz:
https://doaj.org/article/7f6a68e66aeb498b9999712860e883dd
Autor:
Romina Salpini, Lorenzo Piermatteo, Giulia Torre, Stefano D'Anna, Sohaib Khan, Leonardo Duca, Ada Bertoli, Simone La Frazia, Vincenzo Malagnino, Elisabetta Teti, Marco Iannetta, Pierpaolo Paba, Marco Ciotti, Ilaria Lenci, Simona Francioso, Caterina Paquazzi, Miriam Lichtner, Claudio Mastroianni, Francesco Santopaolo, Giuseppe De Sanctis, Adriano Pellicelli, Giovanni Galati, Alessandra Moretti, Katia Casinelli, Luciano Caterini, Nerio Iapadre, Giustino Parruti, Iacopo Vecchiet, Maurizio Paoloni, Massimo Marignani, Francesca Ceccherini-Silberstein, Leonardo Baiocchi, Sandro Grelli, Loredana Sarmati, Valentina Svicher
Publikováno v:
International Journal of Infectious Diseases, Vol 138, Iss , Pp 1-9 (2024)
Objectives: Here we investigate Hepatitis D virus (HDV)-prevalence in Italy and its fluctuations over time and we provide an extensive characterization of HDV-infected patients. Methods: The rate of HDV seroprevalence and HDV chronicity was assessed
Externí odkaz:
https://doaj.org/article/dfff0b10a44f46228c9d61eb4e68b98e
Autor:
Marialaura Fanelli, Vita Petrone, Christian Maracchioni, Rossella Chirico, Chiara Cipriani, Luigi Coppola, Vincenzo Malagnino, Elisabetta Teti, Chiara Sorace, Marta Zordan, Pietro Vitale, Marco Iannetta, Emanuela Balestrieri, Guido Rasi, Sandro Grelli, Fabrice Malergue, Loredana Sarmati, Antonella Minutolo, Claudia Matteucci
Publikováno v:
Current Research in Microbial Sciences, Vol 6, Iss , Pp 100215- (2024)
The use of CD169 as a marker of viral infection has been widely discussed in the context of COVID-19, and in particular, its crucial role in the early detection of SARS-CoV-2 infection and its association with the severity and clinical outcome of COV
Externí odkaz:
https://doaj.org/article/84e9f13ff7d04d1da30f261a38d521da
Autor:
Lorenzo Piermatteo, Stefano D’Anna, Ada Bertoli, Maria Bellocchi, Luca Carioti, Lavinia Fabeni, Mohammad Alkhatib, Simone La Frazia, Miriam Lichtner, Claudio Mastroianni, Giuseppe De Sanctis, Massimo Marignani, Caterina Pasquazzi, Nerio Iapadre, Giustino Parruti, Giuseppina Cappiello, Jacopo Vecchiet, Vincenzo Malagnino, Sandro Grelli, Francesca Ceccherini-Silbertein, Massimo Andreoni, Loredana Sarmati, Valentina Svicher, Romina Salpini
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 1 (2023)
ABSTRACTSpecific HBsAg mutations are known to hamper HBsAg recognition by neutralizing antibodies thus challenging HBV-vaccination efficacy. Nevertheless, information on their impact and spreading over time is limited. Here, we characterize the circu
Externí odkaz:
https://doaj.org/article/1b43cf2280ad42c3a779f94d738ea759
Autor:
Vincenzo Malagnino, Tiziana Mulas, Elisabetta Teti, Monica Basso, Mario Giobbia, Nicholas Geremia, Giuliana Battagin, Yasmine Abi Aad, Jean-Paul Vincensini, Marco Iannetta, Saverio Giuseppe Parisi, Loredana Sarmati, Karine Lacombe
Publikováno v:
Viruses, Vol 16, Iss 3, p 348 (2024)
Hepatitis B Core antibody (HBcAb) positivity is the surrogate marker of hepatitis B occult infection. This condition is not a contraindication for switching to two-drug (2DR) antiretroviral therapy; however, the removal of tenofovir may contribute to
Externí odkaz:
https://doaj.org/article/4a4474e3306940a889baefea65d2e6df
Autor:
Daniele Armenia, Federica Forbici, Ada Bertoli, Giulia Berno, Vincenzo Malagnino, Roberta Gagliardini, Vanni Borghi, William Gennari, Stefania Cicalini, Annarita Buonomini, Elisabetta Teti, Simone Lanini, Alessandra Latini, Loredana Sarmati, Cristina Mussini, Massimo Andreoni, Andrea Antinori, Carlo F. Perno, Francesca Ceccherini-Silberstein, Maria M. Santoro
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 30, Iss , Pp 326-334 (2022)
ABSTRACT: Objectives: We evaluated virological response and resistance profiles in individuals who were virologically suppressed who switched to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in real life. Methods: Survival analysis was us
Externí odkaz:
https://doaj.org/article/19a4d88032234c1f859a709f2608990c
Autor:
Valentina Svicher, Romina Salpini, Stefano D’Anna, Lorenzo Piermatteo, Marco Iannetta, Vincenzo Malagnino, Loredana Sarmati
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
HBV is one of the most widespread hepatitis viruses worldwide, and a correlation between chronic infection and liver cancer has been clearly reported. The carcinogenic capacity of HBV has been reported for other solid tumors, but the largest number o
Externí odkaz:
https://doaj.org/article/daa1762008174e56b7aab88a55bfe5de
Autor:
Andrea Di Lorenzo, Laura Campogiani, Marco Iannetta, Roberta Iannazzo, Alessandra Imeneo, Grazia Alessio, Veronica D’Aquila, Barbara Massa, Ilenia Fato, Lorenzo Vittorio Rindi, Vincenzo Malagnino, Elisabetta Teti, Massimo Andreoni, Loredana Sarmati
Publikováno v:
Antibiotics, Vol 12, Iss 9, p 1348 (2023)
Co-infections during COVID-19 may worsen patients’ outcomes. This study reports the results of a screening assessing the presence of co-infections among patients hospitalized for SARS-CoV-2 infection in the Infectious Diseases-Ward of the Policlini
Externí odkaz:
https://doaj.org/article/5ce6ee42049b4ec8a2d9b9061ebbc0d9
Autor:
Carmen Gratteri, Francesca Alessandra Ambrosio, Antonio Lupia, Federica Moraca, Bruno Catalanotti, Giosuè Costa, Maria Bellocchi, Luca Carioti, Romina Salpini, Francesca Ceccherini-Silberstein, Simone La Frazia, Vincenzo Malagnino, Loredana Sarmati, Valentina Svicher, Sharon Bryant, Anna Artese, Stefano Alcaro
Publikováno v:
Pharmaceuticals, Vol 16, Iss 8, p 1143 (2023)
(1) Background: SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) is a promising therapeutic target to fight COVID-19, and many RdRp inhibitors nucleotide/nucleoside analogs, such as remdesivir, have been identified or are in clinical studies. However,
Externí odkaz:
https://doaj.org/article/1ddea422ece3462aa463e80a8b00dcca
Autor:
Maria Concetta Bellocchi, Rossana Scutari, Luca Carioti, Marco Iannetta, Greta Marchegiani, Lorenzo Piermatteo, Luigi Coppola, Simona Tedde, Leonardo Duca, Vincenzo Malagnino, Lorenzo Ansaldo, Neva Braccialarghe, Stefano D′Anna, Maria Mercedes Santoro, Andrea Di Lorenzo, Romina Salpini, Elisabetta Teti, Valentina Svicher, Massimo Andreoni, Loredana Sarmati, Francesca Ceccherini-Silberstein, on behalf of the PTV-UTV-ID-COVID Group
Publikováno v:
Viruses, Vol 15, Iss 8, p 1711 (2023)
In this study, we provided a retrospective overview in order to better define SARS-CoV-2 variants circulating in Italy during the first two years of the pandemic, by characterizing the spike mutational profiles and their association with viral load (
Externí odkaz:
https://doaj.org/article/048e6d26bb324ffb9567c7183fa88fa5